iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Zydus Lifesciences Ltd News Today

878.65
(0.57%)
May 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Company

Sectoral

Zydus Wins USFDA Approval for Cholesterol Drug

The medication is also prescribed to lower the risk of another heart attack in individuals with a past history of myocardial infarction and hyperlipidaemia

30 Apr 2025|11:25 PM
Zydus Lifesciences Gets USFDA Nod for Niacin ER Tablets in Multiple Strengths

USFDA's final approval is available for Zydus Lifesciences and group companies, and this will allow the group to sell the product in the highly regulated US market.

30 Apr 2025|03:28 PM
Zydus Gets USFDA Nod for Jaythari Tablets

The approval includes various strengths of Jaythari, 6 mg, 18 mg, 30 mg, and 36 mg, which adds to Zydus' portfolio of products in the US generic pharma market.

16 Apr 2025|10:54 AM
Zydus Lifesciences sets up new unit in France

As per the company’s filing, this new subsidiary will be the vehicle through which Zydus plans to acquire the equity shares of Amplitude Surgical SA.

15 Apr 2025|08:58 AM
Top Stocks for Today - 15th April 2025

Here are some of the stocks that may see significant price movement today: GAIL, Zydus Lifesciences, Aurobindo Pharma, etc.

15 Apr 2025|06:15 AM
Zydus Lifesciences gets USFDA approval for apalutamide tablets

As per the IQVIA MAT January 2025 data, apalutamide tablets registered annual sales of $1099.80 million in the United States markets.

19 Mar 2025|11:30 AM
Top Stocks for Today - 19th March 2025

Here are some of the stocks that may see significant price movement today: Bajaj Auto, NTPC, GR Infraprojects, etc.

18 Mar 2025|11:57 PM
Top Stocks for Today - 17th March 2025

Here are some of the stocks that may see significant price movement today: Dalmia Bharat, Galaxy Surfactants, Tata Motors, etc.

17 Mar 2025|07:01 AM
Zydus Lifesciences' Gujarat Unit Clears USFDA Inspection

The inspection concluded with “NIL observations,” the firm said in a regulatory filing, underlining its strong compliance with quality and manufacturing practices.

16 Mar 2025|09:28 PM
Zydus Lifesciences to Acquire 100% Stake in Amplitude Surgical for €300 Million

The deal is subject to signing a put option agreement, share purchase agreements and other relevant contracts for acquisition of controlling shareholding of Amplitude Surgical SA, directly or through Zydus' affiliates.

13 Mar 2025|11:27 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.